Sort   by:  
 Page size 
UnknownRandomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.
Not available
S-EPMC12357863 | biostudies-literature
UnknownDifferential effects of donor-specific HLA antibodies in living versus deceased donor transplant.
Not available
S-EPMC6175247 | biostudies-literature
UnknownToward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.
Not available
S-EPMC6430591 | biostudies-literature
UnknownPretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.
Not available
S-EPMC6115667 | biostudies-literature
UnknownAllocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
Not available
S-EPMC6790659 | biostudies-literature
UnknownAntibodies against ARHGDIB are associated with long-term kidney graft loss.
Not available
S-EPMC6899679 | biostudies-literature
UnknownDevelopment and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.
Not available
S-EPMC6315148 | biostudies-literature
UnknownCurrent practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.
Not available
S-EPMC10364769 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownTwo-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide.
Not available
S-EPMC2843768 | biostudies-literature
Sort   by:  
 Page size